From Plants to Therapies: Exploring the Pharmacology of Coumestrol for Neurological Conditions.

AD Coumestrol Neurological Diseases PD Pharmacological Aspects Phytoestrogen

Journal

Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157

Informations de publication

Date de publication:
26 Oct 2023
Historique:
received: 22 03 2023
revised: 30 06 2023
accepted: 11 09 2023
medline: 3 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: aheadofprint

Résumé

Neurological disorders are possibly the most prevalent and have been identified to occur among individuals with autism beyond chance. These disorders encompass a diverse range of consequences with neurological causes and have been regarded as a major threat to public mental health. There is no tried-and-true approach for completely protecting the nervous system. Therefore, plant-derived compounds have developed significantly nowadays. Coumestrol (CML) is a potent isoflavone phytoestrogen with a protective effect against neurological dysfunction and has been discovered to be structurally and functionally similar to estrogen. In recent years, more research has been undertaken on phytoestrogens. This research demonstrates the biological complexity of phytoestrogens, which consist of multiple chemical families and function in various ways. This review aimed to explore recent findings on the most significant pharmacological advantages of CML by emphasising neurological benefits. Numerous CML extraction strategies and their pharmacological effects on various neurological disorders, including PD, AD, HD, anxiety, and cognitive impairments, were also documented.

Identifiants

pubmed: 37921179
pii: CMC-EPUB-135661
doi: 10.2174/0109298673250784231011094322
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Madhav Singla (M)

Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 40401, India.

Smriti Verma (S)

Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India.

Kiran Thakur (K)

Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India.

Ahsas Goyal (A)

Institute of Pharmaceutical Research, GLA University, U.P., India.

Vishal Sharma (V)

M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, India.

Diksha Sharma (D)

Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, 136119, India.

Omji Porwal (O)

Department of Pharmacognosy, Faculty of Pharmacy, Ishik University, Erbil, Kurdistan, Iraq.

Vetriselvan Subramaniyan (V)

Faculty of Medicine, Bioscience and Nursing, MAHSA University, Saujana Putra, 42610, Selangor, Malaysia.

Tapan Behl (T)

School of health science and technology, University of petroleum science and energy studies, Dehradun, Uttarakhand, India.

Sachin Kumar Singh (SK)

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia.

Kamal Dua (K)

Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia.
Discipline of Pharmacy, Graduate School of Health, the University of Technology Sydney, Ultimo, NSW2007, Australia.

Gaurav Gupta (G)

School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India.
Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.

Saurabh Gupta (S)

Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab140401, India.

Classifications MeSH